cbdMD

YCBD50

Penny Stock

$0.46arrow_drop_up0.13%$0.00

Penny Stock

YCBD50

$0.46

arrow_drop_up0.13%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.46
Prev. Close	$0.46
EPS	-10.90
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$1.73M
PE Ratio	-

	LOW	HIGH
Day Range	0.44	0.48
52 Week Range	0.41	1.73

Ratios

Revenue	-





EPS	-10.90

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About cbdMD (YCBD)

cbdMD Inc (YCBD) is a company that specializes in the production and distribution of CBD products. The company's stock price history has shown significant volatility over the years, with fluctuations in response to market conditions and industry trends. Investors should carefully analyze the stock's performance and market trends before making any investment decisions. It is important to note that past performance is not indicative of future results.

cbdMD Inc (YCBD) operates in the CBD industry, which has experienced rapid growth in recent years. The company offers a wide range of CBD products, including oils, capsules, gummies, and topicals. These products are marketed as natural alternatives for various health and wellness concerns. Industry analysts predict continued growth in the CBD market, driven by increasing consumer awareness and demand for alternative healthcare options.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. T. Ronan Kennedy
Headquarters: Charlotte
Employees: 90
Exchange: NYSE

Keep an eye on cbdMD

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is cbdMD 's (YCBD) price per share?

The current price per share for cbdMD (YCBD) is $0.46. The stock has seen a price change of $0 recently, indicating a 0.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for cbdMD (YCBD)?

For cbdMD (YCBD), the 52-week high is $1.73, which is 275.68% from the current price. The 52-week low is $0.42, the current price is 9.9% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is cbdMD (YCBD) a growth stock?

cbdMD (YCBD) has shown an average price growth of -6.03% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying cbdMD as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is cbdMD (YCBD) stock price performance year to date (YTD)?

As of the latest data, cbdMD (YCBD) has a year-to-date price change of -53.13%. Over the past month, the stock has experienced a price change of -11.43%. Over the last three months, the change has been -16.27%. Over the past six months, the figure is -34.12%. Looking at a longer horizon, the five-year price change stands at -99.69%.

help

Is cbdMD (YCBD) a profitable company?

cbdMD (YCBD) has a net income of -$22.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 62.01% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.38% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $14.98M. Operating income is noted at -$9.27M. Furthermore, the EBITDA is $7.39M.

help

What is the market capitalization of cbdMD (YCBD)?

cbdMD (YCBD) has a market capitalization of $1.73M. The average daily trading volume is 0.47, indicating the stock's liquidity and investor engagement.